The pH-triggered polyglutamate brush co-delivery of MDR1 and survivin-targeting siRNAs efficiently overcomes multi-drug resistance of NSCLC

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA A Cancer J Clin. 2019;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Cao L, Chen J, Ou B, et al. GAS5 knockdown reduces the chemo-sensitivity of non-small cell lung cancer (NSCLC) cell to cisplatin (DDP) through regulating miR-21/PTEN axis. Biomed Pharmacother. 2017;93:570–579.
   PubMed Web of Science ®Google Scholar
• Bao SM, Hu QH, Yang WT, et al. Targeting epidermal growth factor receptor in non-small-cell-lung cancer: current state and future perspective. ACAMC. 2019;19(8):984–991.
   Google Scholar
• Ettinger DS, Wood DE, Aggarwal C, OCN, et al. Non–small cell lung cancer, version 1.2020 featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2019;17(12):1464–1472.
   PubMed Web of Science ®Google Scholar
• Florea AM, Busselberg D. Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers (Basel). 2011;3(1):1351–1371.
   PubMedGoogle Scholar
• Milošević B, Pejić D, Momčičević D, et al. Quality of life in lung cancer patients due to treatment. Signa Vitae. 2016;11:47–50.
   Web of Science ®Google Scholar
• Schmidt SM, Schag K, MüLler MR, et al. Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells. Blood. 2003;102(2):571–576.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhu M, Feng Y, et al. The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-kappaB signal pathway in nasopharynx carcinoma. Biosci Rep. 2020;40:1–8.
   Web of Science ®Google Scholar
• Alfarouk KO, Stock CM, Taylor S, et al. Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp. Cancer Cell Int. 2015;15:71.
   PubMed Web of Science ®Google Scholar
• Garg H, Suri P, Gupta JC, et al. Survivin: a unique target for tumor therapy. Cancer Cell Int. 2016;16:49.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zou H, Wang Z, et al. Highly stable polyglutamate derivatives/siRNA polyplex efficiently down-relegate survivin expression and augment the efficacy of cisplatin. Int J Pharm. 2016;505(1–2):24–34.
   PubMedGoogle Scholar
• Gao Y, Chen L, Zhang Z, et al. Reversal of multidrug resistance by reduction-sensitive linear cationic click polymer/iMDR1-pDNA complex nanoparticles. Biomaterials. 2011;32(6):1738–1747.
   PubMed Web of Science ®Google Scholar
• Wang Z, Bai F, Zhang X, et al. GGI as a gene carrier delivering MDR1 siRNA to A549/DDP cells for reversal of multidrug resistance. Yao Xue Xue Bao. 2017;52(2):309–317.
   PubMedGoogle Scholar
• Li Y, Yang J, Xu B, et al. Enhanced therapeutic siRNA to tumor clls by a pH-sensitive agmatine–chitosan bioconjugate. ACS Appl Mater Interfaces. 2015;7(15):8114–8124.
   PubMed Web of Science ®Google Scholar
• Cho EC, Xie J, Wurm PA, et al. Understanding the role of surface charges in cellular adsorption versus internalization by selectively removing gold nanoparticles on the cell surface with a I2/KI etchant. Nano Lett. 2009;9(3):1080–1084.
   PubMed Web of Science ®Google Scholar
• Kim DH, Seo J, Na K. pH-sensitive carbon dots for enhancing photomediated antitumor immunity. Mol Pharm. 2020;22:1–30.
   Google Scholar
• Qi Q, Zeng X, Peng L, et al. Tumor-targeting and imaging micelles for pH-triggered anticancer drug release and combined photodynamic therapy. J Biomater Sci Polym Ed. 2020;5:1–20.
   Google Scholar
• Chen H, Luo Q, Wang J, et al. Response of pH-sensitive doxorubicin nanoparticles on complex tumor microenvironments by tailoring multiple physicochemical properties. ACS Appl Mater Interfaces. 2020;12(20):22673–22686.
   PubMed Web of Science ®Google Scholar
• Tian H, Guo Z, Lin L, et al. pH-responsive zwitterionic copolypeptides as charge conversional shielding system for gene carriers. J Control Release. 2014; 174:117–125.
   PubMed Web of Science ®Google Scholar
• Blattler TM, Pasche S, Textor M, et al. High salt stability and protein resistance of poly(L-lysine)-g-poly(ethylene glycol) copolymers covalently immobilized via aldehyde plasma polymer interlayers on inorganic and polymeric substrates. Langmuir. 2006;22(13):5760–5769.
   PubMed Web of Science ®Google Scholar
• Nowak AP, Breedveld V, Pine DJ, et al. Unusual salt stability in highly charged diblock co-polypeptide hydrogels. J Am Chem Soc. 2003;125(50):15666–15670.
   PubMed Web of Science ®Google Scholar
• Oupicky D, Ogris M, Howard KA, et al. Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation. Mol Ther. 2002;5(4):463–472.
   PubMed Web of Science ®Google Scholar
• Mechetner E, Kyshtoobayeva A, Zonis S, et al. Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin. Clin Cancer Res. 1998;4:389–398.
   PubMed Web of Science ®Google Scholar
• Vaidyanathan A, Sawers L, Gannon AL, et al. ABCB1 (MDR1) induction defines a common resistance mechanism in paclitaxel- and olaparib-resistant ovarian cancer cells. Br J Cancer. 2016;115(4):431–441.
   PubMed Web of Science ®Google Scholar
• Chang YC, Kondapuram SK, Yang TH, et al. The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells. Toxicol Appl Pharmacol. 2020;401:115080.
   PubMed Web of Science ®Google Scholar
• Tamm I, Wang Y, Sausville E, et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), bax, caspases, and anticancer drugs. Cancer Res. 1998;58(23):5315–5320.
   PubMed Web of Science ®Google Scholar
• Peery RC, Kyei-Baffour K, Dong Z, et al. Synthesis and identification of a novel lead targeting survivin dimerization for proteasome-dependent degradation. J Med Chem. 2020;9:1–15.
   Google Scholar